Ma J, Sun F, Li C, Zhang Y, Xiao W, Li Z, Pan Q, Zeng H, Xiao G, Yao K, Hong A, An J
1] Institute of Genetic Engineering, Jinan University, National Engineering Research Center of Genetic Medicine, Key Lab for Genetic Medicine of Guangdong Province, Guangzhou, People's Republic of China [2] Central Laboratory, Shanghai 10th People's Hospital of Tongji University, Shanghai, People's Republic of China.
Department of Medical Laboratory, Shanghai 10th People's Hospital of Tongji University, Shanghai, People's Republic of China.
Cell Death Dis. 2014 Aug 14;5(8):e1377. doi: 10.1038/cddis.2014.293.
Nasopharyngeal carcinoma (NPC) is a major malignant tumor of the head and neck region in southern China. The understanding of its underlying etiology is essential for the development of novel effective therapies. We report for the first time that microRNA-940 (miR-940) significantly suppresses the proliferation of a variety of cancer cell lines, arrests cells cycle, induces caspase-3/7-dependent apoptosis and inhibits the formation of NPC xenograft tumors in mice. We further show that miR-940 directly binds to the 3'-untranslated regions of Nestin mRNA and promotes its degradation. Likewise, depletion of Nestin inhibits tumor cell proliferation, arrest cells at G2/M, induces apoptosis and suppresses xenograft tumor formation in vivo. These functions of miR-940 can be reversed by ectopic expression of Nestin, suggesting that miR-940 regulates cell proliferation and survival through Nestin. Notably, we observed reduced miR-940 and increased Nestin levels in NPC patient samples. Protein microarray revealed that knockdown of Nestin in 5-8F NPC cells alters the phosphorylation of proteins involved in the DNA damage response, suggesting a mechanism for the miR-940/Nestin axis. Consistently, depletion of Nestin induced spontaneous DNA damage accumulation, delayed the DNA damage repair process and increased the sensitivity to irradiation and the chemotherapeutic agent doxorubicin. Collectively, our findings indicate that Nestin, which is downregulated by miR-940, can promote tumorigenesis in NPC cells through involvement in the DNA damage response. The levels of microRNA-940 and Nestin may serve as indicators of cancer status and prognosis.
鼻咽癌(NPC)是中国南方头颈部区域的一种主要恶性肿瘤。了解其潜在病因对于开发新型有效疗法至关重要。我们首次报道,微小RNA-940(miR-940)可显著抑制多种癌细胞系的增殖,使细胞周期停滞,诱导半胱天冬酶-3/7依赖性凋亡,并抑制小鼠体内NPC异种移植瘤的形成。我们进一步表明,miR-940直接与巢蛋白(Nestin)mRNA的3'-非翻译区结合并促进其降解。同样,敲低Nestin可抑制肿瘤细胞增殖,使细胞停滞在G2/M期,诱导凋亡并抑制体内异种移植瘤的形成。miR-940的这些功能可通过异位表达Nestin来逆转,这表明miR-940通过Nestin调节细胞增殖和存活。值得注意的是,我们在NPC患者样本中观察到miR-940水平降低和Nestin水平升高。蛋白质微阵列显示,在5-8F NPC细胞中敲低Nestin会改变参与DNA损伤反应的蛋白质的磷酸化,提示了miR-940/Nestin轴的一种机制。一致地,敲低Nestin会诱导自发DNA损伤积累,延迟DNA损伤修复过程,并增加对辐射和化疗药物阿霉素的敏感性。总体而言,我们的研究结果表明,被miR-940下调的Nestin可通过参与DNA损伤反应促进NPC细胞的肿瘤发生。微小RNA-940和Nestin的水平可能作为癌症状态和预后的指标。